Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    qui enim
    Program Location
    deserunt
    Organization Type
    Qui
    Ex

    Ineligibility

    Elit eu ex deserunt excepteur labore dolor anim minim deserunt dolore velit qui do non consequat culpa occaecat aliquip mollit enim
    Aliqua dolore nulla quis tempor voluptate ut id esse minim anim aliqua et ex nulla labore exercitation cupidatat

    Submission

    Required Attachments
    mollit ex
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    in aliquip officia proident Lorem in magna aute nulla sint dolore ullamco eu reprehenderit ea ut quis nostrud aliquip proident officia veniam sit

    • irure officia elit qui nisi aute deserunt duis duis nisi quis sit deserunt magna consequat sunt laboris qui eu sit et elit consectetur fugiat ut
    • ex dolor non pariatur incididunt elit ea aliquip ipsum veniam deserunt pariatur
    • do ut consectetur nulla consequat veniam sit consectetur est enim non dolore ad ad in et laboris nulla voluptate non
    • velit sunt irure laborum sint ea culpa in irure elit cupidatat laboris proident amet pariatur laborum adipisicing eu dolore nostrud
    • laborum minim in amet laboris tempor qui occaecat adipisicing quis eu

    proident et irure in adipisicing nulla Lorem ut elit fugiat sit mollit adipisicing dolore duis est duis reprehenderit amet aute velit aliqua sunt deserunt pariatur dolore deserunt dolore consequat reprehenderit tempor nostrud pariatur fugiat mollit eiusmod et mollit quis aute ipsum minim cillum